Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

JOURNAL ARTICLE published October 2014 in Cancer Science

Authors: Yasuhiro Funahashi | Kiyoshi Okamoto | Yusuke Adachi | Taro Semba | Mai Uesugi | Yoichi Ozawa | Osamu Tohyama | Taisuke Uehara | Takayuki Kimura | Hideki Watanabe | Makoto Asano | Satoshi Kawano | Xavier Tizon | Paul J. McCracken | Junji Matsui | Ken Aoshima | Kenichi Nomoto | Yoshiya Oda